618 related articles for article (PubMed ID: 21054571)
21. Primary cutaneous T-cell lymphoma occurring after organ transplantation.
Ravat FE; Spittle MF; Russell-Jones R
J Am Acad Dermatol; 2006 Apr; 54(4):668-75. PubMed ID: 16546591
[TBL] [Abstract][Full Text] [Related]
22. Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines.
Stoecklinger A; Eticha TD; Mesdaghi M; Kissenpfennig A; Malissen B; Thalhamer J; Hammerl P
J Immunol; 2011 Feb; 186(3):1377-83. PubMed ID: 21187444
[TBL] [Abstract][Full Text] [Related]
23. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
Holla A; Skerra A
Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
[TBL] [Abstract][Full Text] [Related]
25. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
26. Indeterminate cell tumor: a rare dendritic neoplasm.
Rezk SA; Spagnolo DV; Brynes RK; Weiss LM
Am J Surg Pathol; 2008 Dec; 32(12):1868-76. PubMed ID: 18813122
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous CD20-positive T-cell lymphoma.
Martin B; Stefanato C; Whittaker S; Robson A
J Cutan Pathol; 2011 Aug; 38(8):663-9. PubMed ID: 21623866
[TBL] [Abstract][Full Text] [Related]
28. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.
Blakolmer K; Vesely M; Kummer JA; Jurecka W; Mannhalter C; Chott A
Mod Pathol; 2000 Jul; 13(7):766-72. PubMed ID: 10912936
[TBL] [Abstract][Full Text] [Related]
29. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
31. C-KIT expression in primary cutaneous T-cell lymphomas.
Brauns TC; Schultewolter T; Dissemond J; Maschke J; Goos M
J Cutan Pathol; 2004 Oct; 31(9):577-82. PubMed ID: 15330987
[TBL] [Abstract][Full Text] [Related]
32. Integrins alpha4beta7 and alphaEbeta7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis.
Schechner JS; Edelson RL; McNiff JM; Heald PW; Pober JS
Lab Invest; 1999 May; 79(5):601-7. PubMed ID: 10334571
[TBL] [Abstract][Full Text] [Related]
33. Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics.
Kaudewitz P; Stein H; Dallenbach F; Eckert F; Bieber K; Burg G; Braun-Falco O
Am J Pathol; 1989 Aug; 135(2):359-67. PubMed ID: 2551170
[TBL] [Abstract][Full Text] [Related]
34. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
Kempf W; Dummer R; Burg G
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
[TBL] [Abstract][Full Text] [Related]
35. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.
Kamarashev J; Burg G; Mingari MC; Kempf W; Hofbauer G; Dummer R
Am J Pathol; 2001 May; 158(5):1593-8. PubMed ID: 11337356
[TBL] [Abstract][Full Text] [Related]
37. Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas.
Mao X; Orchard G; Russell-Jones R; Whittaker S
Br J Dermatol; 2007 Nov; 157(5):914-21. PubMed ID: 17725669
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas.
Valencak J; Trautinger F; Raderer M; Chott A; Der-Petrossian M; Ivancic-Brandenberger E; Knobler R; Kurtaran A; Hoffmann M
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):13-7. PubMed ID: 19515078
[TBL] [Abstract][Full Text] [Related]
39. Ichthyosiform eruptions in association with primary cutaneous T-cell lymphomas.
Morizane S; Setsu N; Yamamoto T; Hamada T; Nakanishi G; Asagoe K; Iwatsuki K
Br J Dermatol; 2009 Jul; 161(1):115-20. PubMed ID: 19416265
[TBL] [Abstract][Full Text] [Related]
40. Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas.
Sarris AH; Daliani D; Ulmer R; Crow M; Broxmeyer HE; Reiss M; Karasavvas N; Zelenetz AD; Pugh W; Cabanillas F; Deisseroth AB; Duvic M
Clin Cancer Res; 1997 Feb; 3(2):169-77. PubMed ID: 9815669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
